Letter: Early real-world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease-Authors' reply.

التفاصيل البيبلوغرافية
العنوان: Letter: Early real-world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease-Authors' reply.
المؤلفون: Yiu, Tsz Hong, Ko, Yanna, Pudipeddi, Aviv, Natale, Patrizia, Leong, Rupert W
المصدر: Aliment Pharmacol Ther ; ISSN:1365-2036 ; Volume:60 ; Issue:1
بيانات النشر: Wiley
سنة النشر: 2024
المجموعة: PubMed Central (PMC)
نوع الوثيقة: manuscript
اللغة: English
العلاقة: https://doi.org/10.1111/apt.18057Test; https://pubmed.ncbi.nlm.nih.gov/38779926Test
DOI: 10.1111/apt.18057
الإتاحة: https://doi.org/10.1111/apt.18057Test
https://pubmed.ncbi.nlm.nih.gov/38779926Test
رقم الانضمام: edsbas.FAD87B9A
قاعدة البيانات: BASE